Divalproex Sodium
Product Images NDC 50090-3416

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-3416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Divalproex 01)

Chemical Structure (Divalproex 01)
Chemical structure of divalproex sodium, showing the molecular arrangement of the sodium salt of valproic acid including propyl groups and carboxylate functional groups.*
FDA Label Image

Figure 1 (Divalproex 02)

Figure 1 (Divalproex 02)
A bar chart comparing percentage outcomes between placebo (PBO) and Divalproex Sodium (DVPX) across two studies. Study 1 (YMRS) shows 26% for PBO and 60% for DVPX, while Study 2 (MRS) shows 29% for PBO and 58% for DVPX.*
FDA Label Image

Figure 2 (Divalproex 03)

Figure 2 (Divalproex 03)
A cumulative response curve graph comparing Divalproex sodium delayed-release tablets USP with placebo. The x-axis represents the percentage of patients, and the y-axis shows the percentage reduction in CPS rate. The graph indicates improvement above the zero line and worsening below it, with solid and dashed lines representing Divalproex sodium and placebo groups, respectively.*
FDA Label Image

Figure 3 (Divalproex 04)

Figure 3 (Divalproex 04)
A cumulative distribution chart depicting the percentage reduction in CPS rate versus the percentage of patients, comparing high dose (solid line) and low dose (dashed line) groups. The vertical axis shows improvement and worsening percentages, while the horizontal axis shows the patient percentile from 0 to 100.*
FDA Label Image

Figure 4 (Divalproex 05)

Figure 4 (Divalproex 05)
A bar chart comparing two studies labeled 'Study 1' and 'Study 2', each showing two bars representing 'Placebo' and 'Divalproex Sodium'. The vertical axis is numbered from 0 to 6. Both studies show higher values for Placebo bars compared to Divalproex Sodium bars.*
FDA Label Image

Label Image (Lbl500903416)

Label Image (Lbl500903416)
The image shows a white medication bottle label for Divalproex Sodium 250 mg delayed-release unit dose tablets. The label includes the NDC 50090-3416-0 and product number 9063-0. It indicates a package size of 32 tablets and lists the distributor as A-S Medication Solutions, LLC, based in Utah.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.